Eventide Asset Management, LLC Myovant Sciences Ltd. Transaction History

Eventide Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $5.87 Million - $16.7 Million	-800,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.55 - $14.76 $21.8 Million - $49.1 Million	-3,326,131 Reduced 80.61%	800,000 $6.04 Million
Q4 2019 Jan 29, 2020	SELL	$4.2 - $19.21 $2.39 Million - $10.9 Million	-568,786 Reduced 12.11%	4,126,131 $64 Million
Q3 2019 Nov 21, 2019	BUY	$5.19 - $9.46 $2.12 Million - $3.87 Million	409,305 Added 9.55%	4,694,917 $24.4 Million
Q2 2019 Aug 14, 2019	BUY	$8.69 - $25.0 $15.8 Million - $45.4 Million	1,816,591 Added 73.58%	4,285,612 $38.8 Million
Q1 2019 May 15, 2019	BUY	$16.83 - $24.45 $4.45 Million - $6.46 Million	264,313 Added 11.99%	2,469,021 $58.9 Million
Q4 2018 Feb 14, 2019	BUY	$15.01 - $25.2 $1.35 Million - $2.26 Million	89,708 Added 4.24%	2,204,708 $36.2 Million
Q3 2018 Nov 14, 2018	BUY	$19.33 - $26.78 $9.92 Million - $13.7 Million	513,339 Added 32.05%	2,115,000 $56.2 Million
Q2 2018 Aug 14, 2018	BUY	$19.2 - $25.14 $19.7 Million - $25.8 Million	1,028,108 Added 179.25%	1,601,661 $36.6 Million
Q1 2018 May 15, 2018	BUY	$12.46 - $21.32 $267,304 - $457,377	21,453 Added 3.89%	573,553 $12.2 Million
Q4 2017 Feb 14, 2018	BUY	$11.37 - $16.4 $23,877 - $34,440	2,100 Added 0.38%	552,100 $6.98 Million
Q3 2017 Nov 14, 2017	BUY	$9.93 - $15.47 $5.46 Million - $8.51 Million	550,000	550,000 $8.51 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.